Scilex Holding Co - Common Stock par value $0.0001 per share (SCLX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q3 2025

Type / Class: Equity / Common Stock par value $0.0001 per share
Symbol: SCLX on Nasdaq
Shares outstanding: 7,401,182
Price per share: $0.20

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Scilex Holding Co - Common Stock par value $0.0001 per share (SCLX) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SCLX Stock Acquisition JV LLC	21%	-7.4%	$16,117,386	-$805,874	80,586,928	-4.8%	SCLX Stock Acquisition JV LLC	21 Jan 2025
ORAMED PHARMACEUTICALS INC.	9.9%	+62%	$146,543	-$2,953,457	732,717	-95%	Oramed Pharmaceuticals Inc.	31 Mar 2025

Institutional Holders of Scilex Holding Co - Common Stock par value $0.0001 per share (SCLX) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q3	0	$0	-$1,245			$0.20	0
2025 Q2	3,046	$1,000	-$11,031,952	$0	$0	$0.33	1
2025 Q1	44,423,704	$11,038,255	-$1,419,016	$2,833	$3,231	$0.25	75
2024 Q4	49,074,470	$20,921,334	+$6,258,681	$7,803	$5,159	$0.43	95
2024 Q3	34,160,004	$31,583,003	-$5,639,463	$52,332	$94,753	$0.92	90
2024 Q2	39,828,625	$76,861,242	+$22,125,681	$45,355	$236,811	$1.93	85
2024 Q1	28,595,225	$45,465,908	+$3,744,037	$82,998	$335,331	$1.59	89
2023 Q4	26,162,251	$53,367,500	-$5,912,027	$188,292	$204,204	$2.04	89
2023 Q3	29,057,166	$40,677,277	+$8,165,747	$327,040	$179,900	$1.40	77
2023 Q2	21,484,428	$119,656,295	+$48,670,189	$532,150	$623,283	$5.57	88
2023 Q1	12,711,330	$104,208,705	+$103,820,839		$820,000	$8.20	83
2022 Q4	53,004	$240,143	+$240,143			$3.99	7